More than half of patients with a rheumatic disease or immunologic condition undergoing methotrexate treatment reside in states in which the overturning of Roe v. Wade can jeopardize access to medications with abortifacient potential

Saved in:
Bibliographic Details
Published in:Arthritis & rheumatology (Hoboken, N.J.) N.J.), 2023-02, Vol.75 (2), p.328-329
Main Authors: Starzyk, Kathryn, Hoffman, Veena, Su, Zhaohui, Meng, Roger, Bhartia, Mudit, Curhan, Gary, Yoshida, Kazuki, Paulus, Jessica K.
Format: Article
Language:English
Subjects:
Abortifacient Agents
Health Services Accessibility
Humans
Immune System Diseases
Methotrexate
Methotrexate - therapeutic use
Rheumatic diseases
Rheumatic Diseases - drug therapy
United States
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2326-5191
2326-5205
DOI:10.1002/art.42398